Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00293475
Title Rituximab and Methotrexate Chemotherapy w/Blood-Brain Barrier Disruption (BBBD); Sodium Thiosulfate Chemoprotection for Patients With Newly Diagnosed PCNSL
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors OHSU Knight Cancer Institute
Indications

central nervous system lymphoma

Therapies

Filgrastim

Pegfilgrastim

Leucovorin

Carboplatin + Methotrexate + Rituximab

Age Groups: adult
Covered Countries USA


No variant requirements are available.